NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Atherosclerosis and its clinical manifestations of heart attack, stroke, and peripheral vascular insufficiency are a major cause of morbidity and mortality among both men and women. Multiple risk factors including hypertension, diabetes mellitus, smoking, and lipoprotein disorders are involved in the pathogenesis of this chronic inflammatory disease of arteries. The development of early atherosclerotic lesions can be subdivided into initiation (formation of small fatty streaks), expansion (vertical and lateral growth and coalescence of fatty streaks), and progression to plaques (intimal smooth muscle cell recruitment, collagen deposition, and formation of a fibrous cap) (reviewed in ref.1). During the initiation and expansion of fatty streaks, circulating monocytes are recruited to the arterial intima where they are transformed into lipid-engorged macrophage foam cells. The arterial endothelium in these regions is activated and expresses inducible leukocyte adhesion molecules and chemokines. Production of cytokines and growth factors within lesions may amplify monocyte recruitment, stimulate macrophage proliferation, and induce migration of smooth muscle cells from the media to the intima of the vessel. Intimal smooth muscle cells deposit collagen and other ECM proteins, leading to the formation of a fibrous cap. Although clinically significant complications of atherosclerosis, such as plaque ulceration, rupture, and thrombosis, occur in established or advanced atherosclerotic plaques, understanding the mechanisms of early lesion formation offers the hope of intervening to delay or prevent lesion progression and complications. A select set of transcription factors may be critical in both the initiation and expansion of lesions, as well as in protecting the vessel wall from the formation of atherosclerotic lesions. In this overview, we will focus on one transcription factor, NF-κB, whose activation has been linked to the onset of atherosclerosis. NF-κB is composed of members of the Rel family that share a 300 amino acid region, known as the Rel homology domain, which mediates dimerization, nuclear translocation, DNA binding, and interaction with NF-κB inhibitors (reviewed in ref.2). Activation of NF-κB is controlled by a family of inhibitors, or IκBs, that bind to NF-κB dimers and mask the nuclear localization sequence of NF-κB, thus retaining the entire complex in the cytoplasm. Diverse stimuli activate NF-κB, through the phosphorylation and activation of the IκB kinase (IKK) complex. This complex consists of IKK-α and IKK-β heterodimers, a number of IKK-γ subunits, and possibly other components that have less certain significance. The activated IKK complex specifically phosphorylates the IκBs, which are then rapidly polyubiquitinated, targeting them for degradation by the proteosome. Following release from the inhibitor, NF-κB dimers translocate from the cytoplasm to the nucleus, where they bind target genes and stimulate transcription (Figure (Figure1).1). NF-κB activates a variety of target genes relevant to the pathophysiology of the vessel wall, including cytokines, chemokines, and leukocyte adhesion molecules, as well as genes that regulate cell proliferation and mediate cell survival. NF-κB also activates the IκBα gene, thus replenishing the cytoplasmic pool of its own inhibitor. Restored expression of IκB-α decreases NF-κB activation and diminishes expression of NF-κB–dependent genes. The NF-κB/IκB-α autoregulatory system ensures that the induction of NF-κB is transient and that the activated cell returns to a quiescent state. Physiological modulation and pathological activation of the NF-κB system may contribute to the changes in gene expression that occur during atherogenesis. Figure 1 Schematic representation of NF-κB as an integrator in atherogenesis. Many of the diverse agents associated with the onset of lesion formation interact with specific receptors. Angiotensin II (Ang II), cytokines, advanced glycosylation end products ...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NF-jB is one of the major immune response transcription factors involved in the initiation and development of atherosclerosis (26).”
From Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent (2010) · cites this paper as [26]
Experimental — accuracy not yet measuredIn the citing paper
“However, the regulation of NF-jB activation by zinc appears to be cell specific.”
In the citing paper
“Zinc plays an important role in NF-jB activation.”
In the citing paper
“We and other investigators (26,28) reported that zinc is required for NF-jB DNA binding in purified or recombinant NF-jB p50 protein or T helper cell lines.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965 · cited 1×
“(7) crossed CCR2-deficient animals with mice lacking apoE.”
BackgroundPPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,712
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Antioxidants and Atherosclerotic Heart Disease
Diaz, M. N., Frei, B., Vita, J. A., & Keaney, J. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370607 · Cited by 1,353
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 798
Schmidt, A. M., Yan, S. D., Wautier, J.-L., & Stern, D. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 791
Is NF-kappaB the sensor of oxidative stress?
Li, N., & Karin, M. (1999) · PubMed · Cited by 786
Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB
Peng, H.-B., Libby, P., & Liao, J. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.14214 · Cited by 710
Is NF‐κB the sensor of oxidative stress?
Li, N., & Karin, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1137 · Cited by 701
Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α
Imbert, V., Rupec, R. A., Livolsi, A., Pahl, H. L., Traenckner, E. B.-M., Mueller-Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Baeuerle, P. A., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80153-1 · Cited by 660
The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation
Karin, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27339 · Cited by 640
Iiyama, K., Hajra, L., Iiyama, M., Li, H., DiChiara, M., Medoff, B. D., & Cybulsky, M. I. (1999) · Circulation Research · doi:10.1161/01.res.85.2.199 · Cited by 632
Hostile takeovers: viral appropriation of the NF-kB pathway
Hiscott, J., Kwon, H., & Génin, P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11918 · Cited by 613
Hajra, L., Evans, A. I., Chen, M., Hyduk, S. J., Collins, T., & Cybulsky, M. I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9052 · Cited by 574
Libby, P., Egan, D., & Skarlatos, S. (1997) · Circulation · doi:10.1161/01.cir.96.11.4095 · Cited by 556
Kol, A., Sukhova, G. K., Lichtman, A. H., & Libby, P. (1998) · Circulation · doi:10.1161/01.cir.98.4.300 · Cited by 538
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J.-F., & Michel, J.-B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 517
Khan, B. V., Parthasarathy, S. S., Alexander, R. W., & Medford, R. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117776 · Cited by 463
Morigi, M., Angioletti, S., Imberti, B., Donadelli, R., Micheletti, G., Figliuzzi, M., Remuzzi, A., Zoja, C., & Remuzzi, G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci656 · Cited by 438
Tummala, P. E., Chen, X.-L., Sundell, C. L., Laursen, J. B., Hammes, C. P., Alexander, R. W., Harrison, D. G., & Medford, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1223 · Cited by 379
Han, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377
Outinen, P. A., Sood, S. K., Pfeifer, S. I., Pamidi, S., Podor, T. J., Li, J., Weitz, J. I., & Austin, R. C. (1999) · Blood · doi:10.1182/blood.v94.3.959.415k20_959_967 · Cited by 349
IKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex
Peters, R. T., Liao, S.-M., & Maniatis, T. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80445-1 · Cited by 333
Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.
Ishikawa, K., Navab, M., Leitinger, N., Fogelman, A. M., & Lusis, A. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119634 · Cited by 289
Schoonbroodt, S., Ferreira, V., Best-Belpomme, M., Boelaert, J. R., Legrand-Poels, S., Korner, M., & Piette, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4292 · Cited by 263 · cited 1×
“Indeed, there is recent evidence that oxidative stress activates NF-κB through a mechanism that involves Tyr42 of IκB-α and is distinct from that stimulated by cytokines or growth factors (38).”
BackgroundAkimoto, S., Mitsumata, M., Sasaguri, T., & Yoshida, Y. (2000) · Circulation Research · doi:10.1161/01.res.86.2.185 · Cited by 260
Vascular Endothelium, Hemodynamic Forces, and Atherogenesis
Gimbrone, M. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65090-0 · Cited by 260
Expression of heme oxygenase-1 in atherosclerotic lesions.
Wang, L.-J., Lee, T., Lee, F.-Y., Pai, R., & Chau, L. (1998) · Europe PMC (PubMed Central) · Cited by 254
Very Low-Density Lipoprotein Activates Nuclear Factor-κB in Endothelial Cells
Dichtl, W., Nilsson, L., Goncalves, I., Ares, M. P. S., Banfi, C., Calara, F., Hamsten, A., Eriksson, P., & Nilsson, J. (1999) · Circulation Research · doi:10.1161/01.res.84.9.1085 · Cited by 199
Mohan, S., Mohan, N., & Sprague, E. A. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.2.c572 · Cited by 165
Vitamins C and E Inhibit O 2 − Production in the Pig Coronary Artery
Nunes, G. L., Robinson, K., Kalynych, A., King, S. B., Sgoutas, D. S., & Berk, B. C. (1997) · Circulation · doi:10.1161/01.cir.96.10.3593 · Cited by 149
Fluid Shear Stress Activation of IκB Kinase Is Integrin-dependent
Bhullar, I. S., Li, Y.-S., Miao, H., Zandi, E., Kim, M., Shyy, J. Y.-J., & Chien, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30544 · Cited by 140
Wilson, S. H., Caplice, N. M., Simari, R. D., Holmes, D. R., Carlson, P. J., & Lerman, A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00211-7 · Cited by 131
Dysregulation of Monocytic Nuclear Factor-κB by Oxidized Low-Density Lipoprotein
Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., Kaltschmidt, C., Neumann, F., Mackman, N., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.1901 · Cited by 127
Speir, E. H., Shibutani, T., Yu, Z., Ferrans, V. J., & Epstein, S. E. (1996) · Circulation Research · doi:10.1161/01.res.79.6.1143 · Cited by 126
Herpesviruses in Atherosclerosis and Thrombosis: Etiologic Agents or Ubiquitous Bystanders?
Nicholson, A. C., & Hajjar, D. P. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.3.339 · Cited by 89
An Animal Model to Study Local Oxidation of LDL and Its Biological Effects in the Arterial Wall
Calara, F., Dimayuga, P., Niemann, A., Thyberg, J., Diczfalusy, U., Witztum, J. L., Palinski, W., Shah, P. K., Cercek, B., Nilsson, J., et al. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.6.884 · Cited by 84
Erl, W., Weber, C., Wardemann, C., & Weber, P. C. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.2.h634 · Cited by 80
Ammonia effect on calcium-activated chloride secretion in T84 intestinal epithelial monolayers
Mayol, J. M., Hrnjez, B. J., Akbarali, H. I., Song, J. C., Smith, J. A., & Matthews, J. B. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.2.c634 · Cited by 70
Robson, S. C., Nehls, V., & Palmetshofer, A. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614867 · Cited by 66
Homocysteine provokes leukocyte–endothelium interaction by downregulation of nitric oxide
Pruefer, D., Scalia, R. G., & Lefer, A. M. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(99)00045-2 · Cited by 64
Knight, D. A., Waldman, W. J., & Sedmak, D. D. (1999) · Transplantation · doi:10.1097/00007890-199912150-00030 · Cited by 50
The inhibition of endothelial activation by unsaturated fatty acids
De Caterina, R., Spiecker, M., Solaini, G., Basta, G., Bosetti, F., Libby, P., & Liao, J. (1999) · Lipids · doi:10.1007/bf02562285 · Cited by 39
Very-low-density lipoprotein activates nuclear factor kappa B in endothelial cells
Dichtl, W., Nilsson, O., Gonçalves, I., Ares, M. P. S., Banfi, C., Calara, F. B., Hamsten, A., Eriksson, P. O., & Nilsson, J. (1998) · Lund University Publications (Lund University) · Cited by 30
Cited by
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
“Constituents of modified lipoprotein particles, among them certain oxidized phospholipids and short-chain aldehydes arising from lipoprotein oxidation, can induce transcriptional activation of the VCAM-1 gene mediated in part by nuclear factor-κB (NF-κB”
BackgroundNF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Gimbrone, M. A., & García-Cardeña, G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306301 · Cited by 3,476
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Metadata
- Authors
- Collins, T., & Cybulsky, M. I.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Toronto (CA)
- Corresponding author
- Collins, Tucker
- Venue
- Journal of Clinical Investigation
- Published
- 2001-02-01
- Volume
- 107
- Issue
- 3
- Pages
- 255-264
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC199202
- OpenAlex
- W1965772617
- Cited by
- 727
- References
- 51
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 9 · 2023: 15 · 2022: 12 · 2021: 14 · 2020: 18 · 2019: 12 · 2018: 18 · 2017: 28 · 2016: 24 · 2015: 25 · 2014: 34 · 2013: 31 · 2012: 29
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL045462, P50HL056985, P01-HL 36028, P50HL56985., P01HL036028, R01 HL45462)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- NF-κB, atherosclerosis, atherogenesis, Rel family transcription factors, IκB kinase, IκB phosphorylation, IκBα, IκBβ, IκBε
- MeSH terms
- Animals, Aorta, Arteriosclerosis, Endothelium, Vascular, Hemodynamics, Homocysteine, Humans, Hypertension, Leukocytes, Risk Factors, NF-kappa B, Apoptosis, Oxidative Stress, Vascular Cell Adhesion Molecule-1, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.